-
Restoring the Blood-brain Barrier to Prevent Dissemination of Alpha-synuclein and Progression of Parkinson’s Disease
… blood-brain barrier. The cells will be collected from healthy volunteers and individuals with a genetic form of … and determine whether this increased porousness impairs the health of brain cells, such as neurons. Impact on … aimed at preventing barrier dysfunction or restoring a healthy barrier may provide exciting new avenues to treat …
-
Identifying Biomarkers for a Mitochondrial Subtype of Parkinson’s Disease
… tests. Working with several hundred people with PD and healthy individuals, we will obtain two types of blood cells … will make it possible to steer those persons toward experimental treatments designed specifically to improve … a simpler test method that can be routinely applied at most health institutions. …
-
Glucocerebrosidase Activation as a Therapeutic Strategy for Parkinson’s Disease
… a recycling center that maintains overall cellular health. We plan to alleviate these disease-related molecular … individuals with GBA1 mutations or iPD compared to those of healthy volunteers. Impact on Diagnosis/Treatment of …
-
Therapeutic Targeting of Mitochondrial Biogenesis to Address Parkinson’s Disease
… in the development of PD. Therefore, drugs that support the health and function of these cellular powerhouses could be …
-
What You Need to Know about Sleep, Aging and Parkinson's
March 15, 2023
… Disorders, The Research Institute of the McGill University Health Centre View a transcript of this podcast. The …
-
Michael J. Fox and Foundation Leadership Accept Advocacy/Policy Award from Reagan-Udall Foundation for the FDA
December 9, 2020
… or organizations that have made an impact to improve public health through advocacy — was conferred to the Foundation at …